Celldex Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.0M | 47k | 41.97 |
| 2023-12-31 | $3.0M | 76k | 39.66 |
| 2023-09-30 | $1.7M | 63k | 27.52 |
| 2023-06-30 | $3.4M | 100k | 33.93 |
| 2023-03-31 | $483k | 13k | 35.97 |
| 2022-12-31 | $2.1M | 48k | 44.57 |
| 2022-06-30 | $1.1M | 42k | 26.96 |
| 2022-03-31 | $1.2M | 35k | 34.08 |
| 2021-12-31 | $4.9M | 128k | 38.65 |
| 2021-03-31 | $0 | 108 | 0.00 |
| 2020-12-31 | $2.1k | 167 | 12.66 |
| 2020-09-30 | $999 | 66 | 15.15 |
| 2020-06-30 | $999 | 66 | 15.15 |
| 2020-03-31 | $0 | 66 | 0.00 |
| 2019-12-31 | $0 | 66 | 0.00 |
| 2019-09-30 | $0 | 66 | 0.00 |
| 2019-06-30 | $0 | 66 | 0.00 |
| 2019-03-31 | $0 | 66 | 0.00 |